This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hanna, N. Search for Related Content PubMed PubMed Citation Articles by Hanna, N.

Inhibition of Experimental Tumor Metastasis by Selective Activation of Natural Killer Cells¹

Cancer Metastasis and Treatment Laboratory, National Cancer Institute Frederick Cancer Research Facility, Frederick, Maryland 21701

The antitumor activity generated by selective activation of natural killer (NK) cells was studied in vitro and in vivo. Unlike Corynebacterium parvum CN6134, which activated both NK cells and macrophages, periodate-oxidized C. parvum CN6134 lost the ability to activate macrophages but retained almost all the NK-stimulating capacity of the untreated bacterium. The "inactive" C. parvum strain CN5888 also induced a modest, but selective, activation of NK cells. The enhanced NK cell-mediated cytotoxicity was expressed against YAC-1 lymphoma, UV-2237 fibrosarcoma, and B16 melanoma target cells in vitro and was manifested in vivo by increased destruction of circulting tumor cells and the inhibition of hematogenous tumor metastasis. Periodate-treated C. parvum was as effective in inhibiting the formation of B16 melanoma pulmonary metastases as was untreated C. parvum. In both cases, the inhibiting effect corresponded closely with the kinetics of NK cell activation.

¹ Research sponsored by the National Cancer Institute, Department of Health and Human Services, under Contract N01-C0-75380 with Litton Bionetics, Inc.

² Present address: Smith Kline and French Laboratories, 1500 Spring Garden Street, P. O. Box 7929, Philadelphia, Pa. 19101.

Received 10/16/81. Accepted 1/ 7/82.

This article has been cited by other articles:

				K. Takeda and K. Okumura CAM and NK Cells Evid. Based Complement. Altern. Med., June 1, 2004; 1(1): 17 - 27. [Abstract] [Full Text] [PDF]

				M. Hejna, M. Raderer, and C. C. Zielinski Inhibition of Metastases by Anticoagulants J Natl Cancer Inst, January 6, 1999; 91(1): 22 - 36. [Abstract] [Full Text] [PDF]

				S. DeCarvalho Atherosclerosis: I. A Leiomyoproliferative Disease of the Arteries Resulting from Breakdown of the Endothelial Barrier to Potent Blood Growth Factors II. Perspectives in Atheroprophylaxis Angiology, October 1, 1985; 36(10): 697 - 710. [Abstract] [PDF]